KetoSwiss, a Basel, Switzerland-based company that develops products which improve brain energetics, raised $4.8M in second closing of Pre-Series A funding.
The latest financing round was led by The William K. Warren Foundation. Other participating investors included R42 and Healthspan Capital. It was also supported by the Baszucki Group, and ortho innovations, a spinoff from the Orthomol family business.
The company intends to use the funds to expand R&D and clinical development efforts.
Led by CEO and Founder Dr Elena Gross, KetoSwiss develops products which improve brain energetics, a common denominator of many neurological and psychiatric diseases, for which no treatment method is currently available. The first flagship medical food for migraine pairs the brain’s most ancient fuel – ketone bodies – with crucial micronutrients necessary for the brain’s energy metabolism. With this, it offers a holistic, clinically tested and patent-protected solution which will enter the U.S. market end of 2023: MigraKet by Brain Ritual.
FinSMEs
12/08/2023